(Q42995718)

12 November 2017

title

Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patients (English)

1 reference

12 November 2017

1 reference

1 reference

P Fabris

1

1 reference

12 November 2017

G Tositti

2

1 reference

12 November 2017

F Negro

3

1 reference

12 November 2017

F Marranconi

4

1 reference

12 November 2017

D Infantolino

5

1 reference

12 November 2017

M Rassu

6

1 reference

12 November 2017

F De Lalla

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Alimentary Pharmacology & Therapeutics

12 November 2017

published in

1 reference

12 November 2017

volume

13

1 reference

12 November 2017

issue

10

1 reference

12 November 2017

page(s)

1329-1334

1 reference

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

A preliminary experience with GM-CSF plus interferon in patients with HBV and HCV resistant to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

Signal transduction by interferon-alpha through arachidonic acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

An immunoassay for specific amplified HCV sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

Typing of hepatitis C virus isolates by DNA enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

Factors predictive of a beneficial response to therapy of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00613.X

10.1046/J.1365-2036.1999.00613.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference